Joseph M. Amann

3.7k citations
53 papers · 2.7k indexed · h-index 28

Joseph M. Amann

51 papers receiving 2.7k citations

Peers

Joseph M. Amann
Comparison fields: 5 of 95
  • Hematology 346
  • Oncology 825
  • Cancer Research 426
  • Molecular Biology 1.8k
  • Pulmonary and Respiratory Medicine 605
Replace Hiroshi Okuda with:
Hiroshi Okuda Japan
David Tulasne France
Yosef Landesman United States
Pengbo Zhou United States
Qunyan Yu United States
Long‐Yuan Li Taiwan
Péter Sandy United States
Simona Ronzoni Italy
David O. Azorsa United States
Daniel J. Murphy United Kingdom
Joseph M. Amann relative to Hiroshi Okuda Japan Hiroshi Okuda's profile →
Citations per field
00.5×1.5×1.8×
Hiroshi Okuda · 1×
Citations per year

Countries citing papers authored by Joseph M. Amann

Since Specialization
Citations

This map shows the geographic impact of Joseph M. Amann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph M. Amann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph M. Amann more than expected).

Fields of papers citing papers by Joseph M. Amann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph M. Amann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph M. Amann. The network helps show where Joseph M. Amann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Joseph M. Amann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joseph M. Amann Line = papers co-authored together Joseph M. Amann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202110
2 202117
3 202059
4 201915
5 201811
6 201731
7 201619
8 201517
9 201512
10 201491
11 20143
12 201261
13 2008216
14 2008291
15 200750
16 200634
17
Acquired EGFr TKI resistance associated with mutation of the EGFr.
20041
18 200320
19 200144
20 1994106

About Joseph M. Amann

Joseph M. Amann is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 53 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), RNA modifications and cancer (7 papers), Histone Deacetylase Inhibitors Research (5 papers), Cancer Genomics and Diagnostics (5 papers), Epigenetics and DNA Methylation (5 papers), Lung Cancer Research Studies (5 papers), Peptidase Inhibition and Analysis (4 papers) and Acute Myeloid Leukemia Research (4 papers). The work is most often cited by research in Hematology (346 citations), Oncology (825 citations) and Cancer Research (426 citations). Joseph M. Amann has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Scott W. Hiebert, David P. Carbone, Brenda Chyla, Srividya Bhaskara, Sarah K. Knutson, Bart Lutterbach, Stacey S. Huppert, James R. Downing, Zu-Wen Sun and David Cortez. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026